Invention Grant
- Patent Title: Eradication of bacterial biofilm using anti-amyloid monoclonal antibodies
-
Application No.: US17058575Application Date: 2019-05-24
-
Publication No.: US11897942B2Publication Date: 2024-02-13
- Inventor: Cagla Tukel Wilson , Scott Dessain
- Applicant: Temple University—Of The Commonwealth System of Higher Education , LANKENAU INSTITUTE OF MEDICAL RESEARCH
- Applicant Address: US PA Philadelphia
- Assignee: Temple University—Of The Commonwealth System of Higher Education,LANKENAU INSTITUTE OF MEDICAL RESEARCH
- Current Assignee: Temple University—Of The Commonwealth System of Higher Education,LANKENAU INSTITUTE OF MEDICAL RESEARCH
- Current Assignee Address: US PA Philadelphia; US PA Wynnewood
- Agency: Riverside Law LLP
- International Application: PCT/US2019/033897 2019.05.24
- International Announcement: WO2019/226978A 2019.11.28
- Date entered country: 2020-11-24
- Main IPC: C07K16/12
- IPC: C07K16/12 ; A61P31/04
Abstract:
The present invention features compositions comprising an anti-amyloid antibody and methods of treating microbial infection and treating or preventing microbial biofilms using the composition.
Public/Granted literature
- US20210122809A1 ERADICATION OF BACTERIAL BIOFILM USING ANTI-AMYLOID MONOCLONAL ANTIBODIES Public/Granted day:2021-04-29
Information query
